Back to Directory

Omeprazole

Prilosec, Losec

Visual ViewRaw Data

Meta Information

ID:omeprazole
Name:Omeprazole
Schema Version:1.5

Alternate Names

  • Prilosec
  • Losec

Active Compound

omeprazole

Intervention Type

therapeutic_agent

Delivery

Route:
oral
Scope:
  • systemic

Regulatory Status

  • us:rx_drug
  • us:otc_drug
  • eu:rx_drug
  • eu:otc_drug

Indication

Focus:
disease_treatment
Description:
Treatment of conditions caused by excess stomach acid, such as gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis.

Typical Protocol

  • A standard dose is 20-40 mg taken orally once daily, typically 30-60 minutes before the first meal.
  • Treatment duration typically ranges from 2 to 8 weeks, but may be longer for certain conditions under medical supervision.

Expected Cost Mean

Low Cost:
5
High Cost:
20
Cost Type:
monthly
Description:
Generic versions are very inexpensive; often covered by insurance when prescribed.

Summary

Omeprazole is a proton pump inhibitor (PPI) that works by irreversibly blocking the hydrogen/potassium ATPase enzyme system in gastric parietal cells. This action suppresses the final step of stomach acid production, providing potent and long-lasting relief from acid-related symptoms and allowing esophageal and stomach tissue to heal.

Purpose

Reduces stomach acid production to treat GERD and ulcers.

Card Summary

A proton pump inhibitor (PPI) that decreases stomach acid production to treat GERD, peptic ulcers, and related conditions.

Drug Class

proton_pump_inhibitor

Drugs In Class

Empty Array

Impact

Score:
7.8
Justification:
Highly effective at resolving symptoms and healing tissue in acid-related gastrointestinal disorders.

Evidence

Grade:
A
Score:
9.5
Justification:
Extensive, high-quality human RCTs and meta-analyses confirm efficacy for approved indications.

Safety

Score:
5.5
Justification:
Generally safe for short-term use, but long-term use is linked to multiple health risks.

Flags

  • Long-term use is associated with increased risk of bone fractures, kidney disease, and C. difficile infection.
  • May decrease the absorption of essential nutrients like vitamin B12, magnesium, and calcium.
  • Can interact with drugs like clopidogrel (Plavix), reducing their effectiveness.
  • Rebound acid hypersecretion can occur upon discontinuation after prolonged use.

Verdict

Highly effective for short-term acid-related disease; long-term use requires medical supervision.

Qualifier

scope: systemic, focused on disease treatment

Created

2026-05-07T01:07:58.970738Z

Ai Model

Gemini 2.5 Pro (High)

Non Healthspan

True